Cited by 1,872NF-κB Signaling PathwaysUbiquitin and proteasome pathwaysImmune Response and Inflammation

Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain

Open access
Deng, Li, Wang, Chen, Spencer, Erika, Yang, Liyong, Braun, Amy, You, Jianxin, Slaughter, Clive, Pickart, Cecile +1 more·2000·Cell

Abstract

TRAF6 is a signal transducer in the NF-kappaB pathway that activates IkappaB kinase (IKK) in response to proinflammatory cytokines. We have purified a heterodimeric protein complex that links TRAF6 to IKK activation. Peptide mass fingerprinting analysis reveals that this complex is composed of the ubiquitin conjugating enzyme Ubc13 and the Ubc-like protein Uev1A. We find that TRAF6, a RING domain protein, functions together with Ubc13/Uev1A to catalyze the synthesis of unique polyubiquitin chains linked through lysine-63 (K63) of ubiquitin. Blockade of this polyubiquitin chain synthesis, but not inhibition of the proteasome, prevents the activation of IKK by TRAF6. These results unveil a new regulatory function for ubiquitin, in which IKK is activated through the assembly of K63-linked polyubiquitin chains.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(00)00126-4

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A mutant ubiquitin K63R completely abolishes UBC13/UEV1a-mediated ubiquitin chain formation independently of the RING domain.

    “a mutant ubiquitin in which lysine 63 is replaced by an arginine (K63R) completely abolished UBC13/ UEV1a-mediated ubiquitin chain formation independently of the RING domain (19,20) (Fig. 4A).”

    From Distinct Functional Domains Contribute to Degradation of the Low Density Lipoprotein Receptor (LDLR) by the E3 Ubiquitin Ligase Inducible Degrader of the LDLR (IDOL) (2011) · cites this paper as [19]

    The Results report that ubiquitin with lysine 63 replaced by arginine (R63) abolished ubiquitin’s ability to stimulate IKK activation. They do not show that this mutant completely abolished Ubc13/Uev1A-mediated chain formation independently of the RING domain. Instead, the Results and Discussion say that TRAF6-facilitated chain assembly requires an intact RING domain. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 1

  1. [1]1. Baeuerle, P.A ∙ Baltimore, D Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor Cell. 1988; 53:211-217

Cited by

Sorted by citations

Authors
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Johns Hopkins University (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
Chen, Zhijian J
Venue
Cell
Publisher
Elsevier BV
Published
2000-10
Volume
103
Issue
2
Pages
351-361
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2037454778
Cited by
1,872
References
0
Citations by year
2026: 38 · 2025: 49 · 2024: 41 · 2023: 40 · 2022: 78 · 2021: 52 · 2020: 62 · 2019: 61 · 2018: 74 · 2017: 81 · 2016: 64 · 2015: 66 · 2014: 86 · 2013: 77 · 2012: 85
FWCI
22.85
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of General Medical Sciences (GM59203, GM60372, R01GM059203, R01GM060372)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
TRAF6, IκB kinase, NF-κB signaling, Ubc13, RING domain, IKK activation, ubiquitin signaling, inflammatory cytokines
MeSH terms
Amino Acid Sequence, Biopolymers, Cell-Free System, Cloning, Molecular, Enzyme Activation, HeLa Cells, Humans, Ligases, Molecular Sequence Data, Peptide Mapping, Proteins, Transcription Factors, Ubiquitins, Protein Serine-Threonine Kinases, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Dimerization, Polyubiquitin, Ubiquitin-Conjugating Enzymes, Ubiquitin-Protein Ligases, TNF Receptor-Associated Factor 6, I-kappa B Kinase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review